• Ariadne-Dx utilizes Bioinformatic tools to integrate existing data including:

– Contextual scanning of the published literature

– Omics data

– Clinical Trial Data

• The existing data is used to develop pathway models underlying clinical phenotypes

• These models are than used to predict biomarker(s) that are likely to be indicative of the clinical phenotype

• These models are continuously refined on the basis of new biological data